March 31, 2025 4:00 PM EDT | Source: Phio Pharmaceuticals Corp. Continues advancing clinical trial for INSTASYL siRNA lead...
update
Sold approximately 120,000 Nu.Q® Vet Cancer Tests in 2024. Expanded access to the Nu.Q® Vet Cancer Test – now available for...
Salarius Pharmaceuticals, Inc. Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development...
Pyxis Oncology - Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin (“MICVO,” formerly PYX-201),...
- PROSERA Phase 3 in PAH on Track for Topline Data Readout in Fourth Quarter of 2025 - - Registrational...
February 12, 2025 6:54 PM EST | Source: InMed Pharmaceuticals Vancouver, British Columbia--(Newsfile Corp. - February 12, 2025) -...
